Latest Articles
Endometriosis: ‘If I was believed 10 years ago, maybe it wouldn’t be this extensive’ - The Irish Times
Endometriosis: ‘If I was believed 10 years ago, maybe it wouldn’t be this extensive’ The Irish Times
Published: Dec. 4, 2024, 6:02 a.m.
What is Visanne, the endometriosis drug just added to the PBS? - New Zealand Doctor Online
What is Visanne, the endometriosis drug just added to the PBS? New Zealand Doctor Online
Published: Dec. 4, 2024, 1:33 a.m.
NMPA greenlights new endometrial cancer therapy - Investing.com India
NMPA greenlights new endometrial cancer therapy Investing.com India
Published: Dec. 4, 2024, 1:01 a.m.
Innovent & HUTCHMED Win China Approval for Breakthrough Endometrial Cancer Therapy | IVBIY Stock News - StockTitan
Innovent & HUTCHMED Win China Approval for Breakthrough Endometrial Cancer Therapy | IVBIY Stock News StockTitan
Published: Dec. 4, 2024, 12:01 a.m.
Innovent & HUTCHMED Win China Approval for Breakthrough Endometrial Cancer Therapy | HCM Stock News - StockTitan
Innovent & HUTCHMED Win China Approval for Breakthrough Endometrial Cancer Therapy | HCM Stock News StockTitan
Published: Dec. 4, 2024, midnight
Woman's Doctor: Know the symptoms of endometrial cancer - MSN
Woman's Doctor: Know the symptoms of endometrial cancer MSN
Published: Dec. 3, 2024, 8:37 p.m.
Elagolix with add-back therapy found effective and tolerable for endometriosis pain - Contemporary Obgyn
Elagolix with add-back therapy found effective and tolerable for endometriosis pain Contemporary Obgyn
Published: Dec. 3, 2024, 6:36 p.m.
NMPA Grants Conditional Approval to Fruquintinib Plus Sintilimab for pMMR Endometrial Cancer - OncLive
NMPA Grants Conditional Approval to Fruquintinib Plus Sintilimab for pMMR Endometrial Cancer OncLive
Published: Dec. 3, 2024, 5:11 p.m.
Aspira Women's Health Secures $2M ARPA-H Grant for AI-Powered Endometriosis Test | AWH Stock News - StockTitan
Aspira Women's Health Secures $2M ARPA-H Grant for AI-Powered Endometriosis Test | AWH Stock News StockTitan
Published: Dec. 3, 2024, 1 p.m.
Karyopharm Therapeutics Provides Endometrial Cancer Program Update - Investor Relations | Karyopharm Therapeutics
Karyopharm Therapeutics Provides Endometrial Cancer Program Update Investor Relations | Karyopharm Therapeutics
Published: Dec. 3, 2024, 12:01 p.m.
Link copied to clipboard!